BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 9 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $18,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Murchinson Ltd. | 254,437 | $1,209,000 | 0.60% |
| Redmond Asset Management, LLC | 75,000 | $363,000 | 0.11% |
| K.J. Harrison & Partners Inc | 116,446 | $556,000 | 0.08% |
| ARMISTICE CAPITAL, LLC | 375,000 | $1,781,000 | 0.03% |
| Warberg Asset Management LLC | 27,000 | $130,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 45,000 | $214,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 10,752 | $51,000 | 0.00% |
| UBS Group AG | 2,082 | $10,000 | 0.00% |